Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Disease
Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Diseases with Jonathan Rigby Revolo Biotherapeutics
An Empowered Patient Podcast at Medical and Pharma Insider
Jonathan Rigby, CEO of Revolo Biotherapeutics discusses with Karen Jagoda the company's revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system.
A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid arthritis, uveitis, eosinophilic esophagitis and allergic diseases.
Revolo Biotherapeutics website: RevoloBio.com
Transcript of Podcast: http://empoweredpatientradio.com/resetting-the-immune-system-to-drive-long-term-disease-remission-in-autoimmune-and-allergic-diseases-with-jonathan-rigby-revolo-biotherapeutics-transcript
Empowered Patient Website: https://empoweredpatientradio.com
Medical and Pharma Insider Website: https://fcglobalstrategies.com